IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer. Swiss Med Wkly [Internet]. 2015 Dec. 13 [cited 2026 Jan. 10];145(5152):w14215. Available from: https://www.smw.ch/index.php/smw/article/view/2122